1-4 of 4
r-cvp regimen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

Sung-Yong Kim, MD, Seok-Goo Cho, Won-Sik Lee, MD, Suk-Woo Yang, MD, Sung Yong Oh, MD, Hee Bae Ahn, MD, Deok-Hwan Yang, Seong Kyu Park, Jee Ho Chang, MD, Hyo Jung Kim, MD PhD, Min Joung Lee, Jae Wook Yang
Journal: Blood
Blood (2016) 128 (22): 2981.
https://doi.org/10.1182/blood.V128.22.2981.2981
Published: 2016
Journal Articles

An Open-Label, Phase I Study of R-CVP in Combination with Inotuzumab Ozogamicin in Patients with Relapsed/Refractory CD22-Positive B-Cell Non-Hodgkin Lymphoma,

Michinori Ogura, Toshiki Uchida, David A MacDonald, Kiyohiko Hatake, Andrew Davies, Randeep Sangha, Michael Crump, MD, FRCPC, Catherine Thieblemont, MD, Taro Ishibashi, Steven Hua, Luisa Paccagnella, Erik R Vandendries, MD, PhD, Yukio Kobayashi, Kensei Tobinai, MD
Journal: Blood
Blood (2011) 118 (21): 3715.
https://doi.org/10.1182/blood.V118.21.3715.3715
Published: 2011
Journal Articles

Chlorambucil Induced Angioedema of the Tongue in a Patient with Lymphoma.

A. Majid Shojania, MD
Journal: Blood
Blood (2006) 108 (11): 4618.
https://doi.org/10.1182/blood.V108.11.4618.4618
Published: 2006
Journal Articles

Rituximab-CHOP Significantly Improve the Response of Advanced Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT Lymphoma).

Daisuke Ennishi, MD, Yasuhito Terui, MD,PhD, Tomohiro Myojo, MD, Yuko Mishima, MD, Masahiro Yokoyama, MD, Shunji Takahashi, MD,PhD, Kengo Takeuchi, MD,PhD, Kiyohiko Hatake, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 4715.
https://doi.org/10.1182/blood.V108.11.4715.4715
Published: 2006